KG

KING PHARMACEUTICALS,INC

KG

Overview Fund Activity

Delisted

KG was delisted on the 28th of February, 2011.

Back to rankings

Healthcare Drug Manufacturers - General

Financial journalist opinion

Kestrel Group Announces 2025 Second Quarter Financial Results

DALLAS , Aug. 15, 2025 /PRNewswire/ -- Kestrel Group Ltd (NASDAQ: KG) ("KG" or the "Company"), today announced its financial results for the second quarter ended June 30, 2025. For further details regarding the Company's financial performance and condition, please refer to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.

Kestrel Group Announces 2025 Second Quarter Financial Results

See News Rankings

Charts implemented using Lightweight Charts™